{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T23:29:09Z","timestamp":1781998149091,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.medj.2026.101041","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:52:39Z","timestamp":1773413559000},"page":"101041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Matching hallmarks of cancer complexity with N-of-1 precision oncology"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-6837","authenticated-orcid":false,"given":"Vivek","family":"Subbiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2026.101041_bib1","article-title":"Hallmarks of cancer\u2014Then and now, and beyond","volume":"189","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.medj.2026.101041_bib2","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-25-01453","article-title":"Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations","author":"Sicklick","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2026.101041_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.trecan.2017.12.004","article-title":"Challenging Standard-of-Care Paradigms in the Precision Oncology Era","volume":"4","author":"Subbiah","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.medj.2026.101041_bib8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1158\/2159-8290.CD-22-1377","article-title":"N-of-1 Trials in Cancer Drug Development","volume":"13","author":"Gouda","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2026.101041_bib4","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S1470-2045(15)00188-6","article-title":"Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial","volume":"16","author":"Le Tourneau","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.medj.2026.101041_bib5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41591-023-02379-4","article-title":"The NCI-MATCH trial: lessons for precision oncology","volume":"29","author":"O\u2019Dwyer","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2026.101041_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00122","article-title":"Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study","volume":"2","author":"Mangat","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.medj.2026.101041_bib7","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/s41591-025-03918-x","article-title":"Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial","volume":"31","author":"Marchetti","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2026.101041_bib9","article-title":"Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology","volume":"6","author":"Vo","year":"2022","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.medj.2026.101041_bib10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.annonc.2024.08.2337","article-title":"Optimizing Tomorrow\u2019s Drug Development with Project Optimus: Precision Dosing IS Precision Oncology","volume":"35","author":"Subbiah","year":"2024","journal-title":"Ann. Oncol."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026000449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026000449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:36:51Z","timestamp":1773419811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634026000449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666634026000449"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2026.101041","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Matching hallmarks of cancer complexity with N-of-1 precision oncology","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2026.101041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101041"}}